SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,771.72 -1,124.02
( -1.52%)

Global Indices

Nasdaq

51,839.66 468.68
(0.91%)

Dow Jones

7,763.25 38.12
(0.49%)

Hang Seng

66,234.37 -129.83
(-0.20%)

Nikkei 225

10,700.56 5.31
(0.05%)

Forex

USD-INR

95.89 0.16
(0.16%)

EUR-INR

109.08 -0.12
(-0.11%)

GBP-INR

126.82 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

139.68

444716.74

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.86

Back

Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter

Jul 31,2026

Net profit of Sun Pharmaceutical Industries rose 27.04% to Rs 2894.79 crore in the quarter ended June 2026 as against Rs 2278.63 crore during the previous quarter ended June 2025. Sales rose 10.14% to Rs 15183.55 crore in the quarter ended June 2026 as against Rs 13786.07 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	15183.55	13786.07	10
OPM %	29.10	31.20	-
PBDT	5041.62	4691.32	7
PBT	4302.90	3990.77	8
NP	2894.79	2278.63	27

72,771.72 -1,124.02 ( -1.52%)

51,839.66 468.68 (0.91%)

7,763.25 38.12 (0.49%)

66,234.37 -129.83 (-0.20%)

10,700.56 5.31 (0.05%)

95.89 0.16 (0.16%)

109.08 -0.12 (-0.11%)

126.82 -0.30 (-0.24%)

0.60 0.00 (-0.20%)